BSEParmax Pharma LtdMediumNeutral
Announced Thu, 14 Aug · 15:02 IST

Appointment of Secretarial Auditors

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Parmax Pharma Ltd has appointed Mr. Samsad Alam Khan (Membership No. F13629) as its Secretarial Auditor for a first term of five consecutive years, covering FY 2025-26 to FY 2029-30. The appointment is subject to shareholder approval at the upcoming Annual General Meeting. Mr. Khan is a Practicing Company Secretary registered with ICSI and has over 13 years of experience in company law, SEBI LODR regulations, FEMA compliance, and intellectual property rights. The decision was taken at the Board meeting held on August 14, 2025, which also reviewed the unaudited standalone financial results for the quarter ended June 30, 2025.

Likely market impact

This is a routine regulatory compliance appointment required under the Companies Act. It has no material impact on shareholders or the stock price and signals no governance concerns.